more

www.openbiomed.info

Accelerating access to biomedical evidence

Translational science journals: nearly entirely open

Listen with webreader

Using the SCImago Journal & Country Rank (no subscription required, based on SCOPUS data, for which many libraries pay much), it is relatively simple to put in a word like “translational” and discover how many journals have been launched on that theme (at least those indexed by SCOPUS):

Journals with -Translational- in the Title

JOURNAL NAME OPEN ACCESS ? Publisher Gold or Hybrid
Translational Research Post Pub Elsevier Green
Journal of Translational Medicine Yes Biomed Central Gold
Science Translational Medicine Post Pub AAAS Personal Web Site Green
Clinical and Translational Oncology Open Choice Springer US$3000/EUR2000 excl. VAT
Translational Oncology No Neoplasia Press --
American Journal of Translational Research Yes e-Century Gold
Clinical and Translational Science OOnlineOpen Option Wiley-Blackwell US$3000
Journal of Cardiovascular Translational Research Open Choice Springer US$3000/EUR2000 excl. VAT
Translational Stroke Research Open Choice Springer US$3000/EUR2000 excl. VAT
Experimental and Translational Stroke Medicine Yes Biomed Central Gold
Journal of Experimental Stroke and Translational Medicine Yes Society for Experimental Stroke No Author Fee
Drug Delivery and Translational Research Open Choice Springer US$3000/EUR2000 excl. VAT
Translational Oncogenomics Yes Libertas Academica Gold
Open Translational Medicine Journal Yes Bentham Gold

So out of 14 journal titles meeting the “translational” title word criteria, only three have no open access ingest option.  Of course, Elsevier is a green open access publisher (my blog posts on the subject of green OA), and AAAS does have a partial-green policy: “After publication, authors may post the accepted version of the paper on the author’s personal Web site.”  Lots of open access choice with these relatively new journals.

Share

Wed, August 1 2012 » Uncategorized

Leave a Reply